[HTML][HTML] Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean …
A Sleiman, AG Abou Fayad, H Banna… - Journal of Global …, 2021 - Elsevier
Abstract Carbapenem resistance in Enterobacteriaceae, Acinetobacter baumannii, and
Pseudomonas aeruginosa is increasing worldwide, which led the WHO to list these bacteria …
Pseudomonas aeruginosa is increasing worldwide, which led the WHO to list these bacteria …
Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review
YR Saharman, A Karuniawati, JA Severin… - … Resistance & Infection …, 2021 - Springer
Abstract Background Intensive care units (ICUs) in lower-middle income countries (LMICs)
are suspected to constitute a special risk for patients of acquiring infection due to multiple …
are suspected to constitute a special risk for patients of acquiring infection due to multiple …
Virulence Characteristics of Biofilm-Forming Acinetobacter baumannii in Clinical Isolates Using a Galleria mellonella Model
Acinetobacter baumannii is a Gram-negative coccobacillus responsible for severe hospital-
acquired infections, particularly in intensive care units (ICUs). The current study was …
acquired infections, particularly in intensive care units (ICUs). The current study was …
Deciphering multidrug-resistant Acinetobacter baumannii from a pediatric cancer hospital in Egypt
Infection by multidrug-resistant (MDR) Acinetobacter baumannii is one of the major causes
of hospital-acquired infections worldwide. The ability of A. baumannii to survive in adverse …
of hospital-acquired infections worldwide. The ability of A. baumannii to survive in adverse …
Co-Existence of Carbapenemase-Encoding Genes in Acinetobacter baumannii from Cancer Patients
Introduction Acinetobacter baumannii is an opportunistic pathogen, which can acquire new
resistance genes. Infections by carbapenem-resistant A. baumannii (CRAB) in cancer …
resistance genes. Infections by carbapenem-resistant A. baumannii (CRAB) in cancer …
Efflux Pump Activity and Mutations Driving Multidrug Resistance in Acinetobacter baumannii at a Tertiary Hospital in Pretoria, South Africa
ND Nogbou, GM Nkawane, K Ntshane… - International Journal …, 2021 - Wiley Online Library
Acinetobacter baumannii (A. baumannii) has developed several resistance mechanisms.
The bacteria have been reported as origin of multiple outbreaks. This study aims to …
The bacteria have been reported as origin of multiple outbreaks. This study aims to …
Genomic Characterization of Extensively Drug-Resistant NDM-Producing Acinetobacter baumannii Clinical Isolates With the Emergence of Novel blaADC-257
Acinetobacter baumannii has become a major challenge to clinicians worldwide due to its
high epidemic potential and acquisition of antimicrobial resistance. This work aimed at …
high epidemic potential and acquisition of antimicrobial resistance. This work aimed at …
Molecular dissection of carbapenem-resistant Acinetobacter baumannii circulating in Indian hospitals using Whole Genome Sequencing
ABSTRACT Objectives Carbapenem-resistant Acinetobacter baumannii (CRAB) has
acquired worldwide recognition as a serious nosocomial infection. It poses a concern to …
acquired worldwide recognition as a serious nosocomial infection. It poses a concern to …
[PDF][PDF] Research Article Efflux Pump Activity and Mutations Driving Multidrug Resistance in Acinetobacter baumannii at a Tertiary Hospital in Pretoria, South Africa
ND Nogbou, GM Nkawane, K Ntshane, CK Wairuri… - 2021 - academia.edu
1. Background Acinetobacter baumannii (A. baumannii) is one of the nosocomial pathogens
that exhibits high level of resistance to antibiotics [1, 2]. is Gram-negative coccobacillus …
that exhibits high level of resistance to antibiotics [1, 2]. is Gram-negative coccobacillus …
[引用][C] Molecular Detection of Acientobacter Baumannii Isolated from Nosocomial Infections in Baghdad Hospitals
SD Al-Ahmer, AM Moslim, ZHA Al-Asady - Annals of the Romanian Society for Cell …, 2021